By Mark Reynolds • Published: 29 Dec 2020 • 17:30
The European Medical Agency has admitted it’s unlikely to approve the Oxford-based Vaccine in January.
Deputy Executive Director Noel Wathion said the approval was at this time unlikely in January to approve the Oxford/AstraZeneca vaccine due to them receiving limited information on the product so far.
Noel Wathion also indicated approval was improbable due in part to the vaccine manufactures not filing a full application yet.
There is no conditional marketing licence in place, and the additional data was needed. The company needed to apply in respect of all of the points mentioned formally.
Meanwhile, in the UK, it seems the vaccine will receive approval and has its claimed improved its efficacy.
Thank you for taking the time to read this news “ema unlikely to approve oxford vaccine by January ”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.